Brief: Selvita Unit Gets $4.7 Mln Order From US-Based Client
Jan 11 (Reuters) - Selvita SA SLVP.WA :
* SAID ON MONDAY THAT UNIT SELVITA INC. HAS RECEIVED ORDER
FROM
BIOTECHNOLOGY COMPANY BASED IN US WITHIN FRAMEWORK AGREEMENT
* UNDER ORDER THE UNIT IS TO PROVIDE SUPPORT FOR THE
CLIENT'S DRUG
DISCOVERY PLATFORM IN THE FIELD OF MEDICAL CHEMISTRY CONSISTING
IN THE SYNTHESIS OF CHEMICAL COMPOUNDS INDICATED BY THE CUSTOMER
* ORDER'S VALUE AT $4.7 MLN
Source text for Eikon: urn:newsml:reuters.com:*:nEM1nYcrva
Further company coverage: SLVP.WA
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project